Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Big Data and Proactive Pharmacovigilance

Posted on September 20th, 2017 by in Pharmacovigilance

Traditionally thought of as a post-market process, pharmacovigilance is how pharmaceutical companies monitor and address any safety issues that arise once a drug becomes available commercially. However, some companies are now thinking ahead about these potential safety concerns with what is known as “proactive PV”. (more…)

Seeing Research Through a Scientist’s Eyes

Posted on July 26th, 2017 by in Pharma R&D

If it’s your job to create and maintain information solutions designed to be used by scientists, it probably helps if you have real-world experience conducting scientific research, right? (more…)

Predicting Adverse Event Risks and Gaining Insights from Disparate Data

Posted on May 17th, 2017 by in Pharma R&D

The upcoming Bio IT World Conference and Expo will feature two talks from Elsevier Life Sciences consultants, focusing on predicting adverse events in clinical trials and extracting knowledge from multiple data sets. (more…)

How Are You Handling Big Data & Innovation?

Posted on April 28th, 2017 by in Pharma R&D

Although every pharmaceutical company still hopes to find the next blockbuster drug, today’s R&D departments are becoming increasingly focused on developing more targeted therapies. It is the advent of Big Data that has made it possible for researchers to advance precision medicine and targeted drugs (more…)

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6